gabapentin

Generic: gabapentin

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler aphena pharma solutions - tennessee, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

gabapentin 100 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-072
Product ID 71610-072_0ee08c47-adac-4fcb-8824-a7f6fd86cafb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075350
Listing Expiration 2026-12-31
Marketing Start 2014-04-23

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610072
Hyphenated Format 71610-072

Supplemental Identifiers

RxCUI
310430
UNII
6CW7F3G59X
NUI
N0000008486

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA075350 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 90 CAPSULE in 1 BOTTLE (71610-072-60)
  • 270 CAPSULE in 1 BOTTLE (71610-072-92)
  • 360 CAPSULE in 1 BOTTLE (71610-072-94)
source: ndc

Packages (3)

Ingredients (1)

gabapentin (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0ee08c47-adac-4fcb-8824-a7f6fd86cafb", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310430"], "spl_set_id": ["37d4d465-19a5-46db-80dc-0b7334b3343a"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71610-072-60)", "package_ndc": "71610-072-60", "marketing_start_date": "20180523"}, {"sample": false, "description": "270 CAPSULE in 1 BOTTLE (71610-072-92)", "package_ndc": "71610-072-92", "marketing_start_date": "20180523"}, {"sample": false, "description": "360 CAPSULE in 1 BOTTLE (71610-072-94)", "package_ndc": "71610-072-94", "marketing_start_date": "20180523"}], "brand_name": "Gabapentin", "product_id": "71610-072_0ee08c47-adac-4fcb-8824-a7f6fd86cafb", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71610-072", "generic_name": "Gabapentin", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "100 mg/1"}], "application_number": "ANDA075350", "marketing_category": "ANDA", "marketing_start_date": "20140423", "listing_expiration_date": "20261231"}